Afzal Nadeem, Javed Khursheed, Mumtaz Asim, Hussain Shahid, Tahir Romeeza, Ullah Ikram, Akram Muhammad
Department of Immunology, University of Health Sciences, Khayaban-e-Jamia, Punjab, Pakistan.
J Ayub Med Coll Abbottabad. 2010 Oct-Dec;22(4):182-6.
Tuberculosis is a fatal infectious disease, mainly caused by Mycobacterium tuberculosis. Spread of TB is controlled by cell-mediated immunity. Purpose of this study was to determine CD4+ and CD8+ T cell percentages in TB patients.
77 subjects consisted of 39 patients of active tuberculosis and 37 normal healthy individuals were recruited for the study. Among patients, 27 were at different stages of anti-tuberculous therapy while rests of the patients were not taking treatment. Sixteen patients were sputum positive for AFB while other patients were sputum negative for AFB. T cells percentages were determined by flow cytometer.
In TB patients CD4+ and CD8+ T cells percentages were 34.4 +/- 9.8 and 32.0 +/- 9.8 while in controls these were 37.1 +/- 6.9 and 30.2 +/- 7.2 respectively but the difference was statistically insignificant. CD4+ T cell percentage in newly diagnosed TB patients was 28.8 +/- 8.7 while it was 37.9 +/- 8.9 in TB patients who were on therapy and difference was statistically significant whereas difference in CD8+ T-cell percentages was statistically insignificant. A negative correlation between CD8+ T-cells percentage and the duration of ATT was found.
CD4+ and CD8+ T-cells percentages may help to find out the immune status of TB patients before and after the completion of ATT.
结核病是一种致命的传染病,主要由结核分枝杆菌引起。结核病的传播受细胞介导的免疫控制。本研究的目的是确定结核病患者中CD4+和CD8+T细胞的百分比。
招募了77名受试者,包括39名活动性结核病患者和37名正常健康个体进行研究。在患者中,27名处于抗结核治疗的不同阶段,其余患者未接受治疗。16名患者痰涂片抗酸杆菌阳性,其他患者痰涂片抗酸杆菌阴性。通过流式细胞仪测定T细胞百分比。
结核病患者中CD4+和CD8+T细胞百分比分别为34.4±9.8和32.0±9.8,而对照组分别为37.1±6.9和30.2±7.2,但差异无统计学意义。新诊断结核病患者的CD4+T细胞百分比为28.8±8.7,而接受治疗的结核病患者为37.9±8.9,差异有统计学意义,而CD8+T细胞百分比的差异无统计学意义。发现CD8+T细胞百分比与抗结核治疗持续时间呈负相关。
CD4+和CD8+T细胞百分比可能有助于了解结核病患者在抗结核治疗完成前后的免疫状态。